(Reuters) – Johnson & Johnson has only a few million doses of its experimental COVID vaccine in its inventory even as likely U.S. regulatory authorization is only a few weeks away, White House officials said Wednesday.
J&J remains committed to providing 100 million doses by June but deliveries are likely to be “back end loaded” as J&J works with the U.S. government to boost supply, said Jeffrey Zients, the White House’s COVID-19 response coordinator, on a press call.
“Across the last few weeks we’ve learned that there is not a big inventory of Johnson and Johnson. There’s a few million doses that we’ll start with,” Zients said.
(Reporting by Carl O’Donnell)
